道彤投资
@author-1784793658606
以生命科学为根，向硬科技生长
Articles
On Day 5 of Brain-Computer Interface Treatment, a Depression Patient Brought a Lollipop... This Disruptive Therapy Could Win Approval Within a Year | Daotong Family
Minhang District Media Center has launched the "**Go, to the Lab**" series, going behind the scenes at Minhang's frontline research facilities to explore breakthrough technologies. This installment visits **a DaoTong portfolio company — KoSyne NeuroTech**.
Gestalt Tech Closes 150 Million Yuan Angel Round, Dalton Venture Co-Leads | Dalton News
Sets New Record for Largest Angel Round in China's Brain-Computer Interface Space
Mycowave Medical Completes Tens of Millions of RMB Angel Round, with Dalton Venture as Sole Investor, Expanding Non-Invasive Neuromodulation for Home and Diversified Scenarios | Dalton News
Recently, emerging neuromodulation company **MicroVention Medical Technology (Shanghai) Co., Ltd.** (abbreviated as "MicroVention Medical") announced the completion of a tens-of-millions-of-yuan angel funding round. The round was **exclusively invested by Dalton Venture**, marking the company's first external financing since its establishment in 2024.
KoSyne NeuroTech Completes Pre-A Round to Accelerate Clinical Translation of Brain-Computer Interface Neuromodulation Platform | Tong's Family
Recently, **KoSyne NeuroTech** (hereinafter referred to as "KoSyne NeuroTech"), a **Dongtou Family company** specializing in non-invasive brain-computer interfaces and neuromodulation, announced the completion of its **Pre-A funding round** — another key milestone following Dongtou Capital's exclusive angel round investment. **This round was led exclusively by Yunqi Capital, with the proceeds to be used primarily for core technology R&D, clinical translation, and global expansion.**
Daotong Leads Investment in YuanDong Bio, Betting on Bacterial Nanocellulose to Transform Everyday Life | Daotong News
It leverages cutting-edge synthetic-biology innovations to push everyday products like cosmetics toward safer, more sustainable formulations.
Steady Steps Toward Renewal, Momentum Into Waves | DTX 2025 Annual Review
Those who walk deeper into the cycle always spot the next beam of light.
Astribot's Self-Developed Lumo-1 Model: Enabling Robots to Unite Mind and Hand, Entering the Era of Reasoning-Action Loops | DaoTong Family
On December 11, 2025, **Datong Family company Astribot released LUMO-1, a next-generation embodied reasoning VLA model that successfully established a new paradigm for the robot "reasoning-action" closed loop**. Leveraging core technologies including a three-stage training architecture and structured reasoning, the model comprehensively outperformed mainstream baselines on critical tasks such as long-horizon multi-step manipulation and out-of-distribution generalization, enabling responses without programming.
A Decade of Dalton, Igniting a New Chapter of Intelligence | Dalton Venture's 2025 Annual Partners Meeting and 10th Anniversary Forum Concludes Successfully
Together, Toward the Brilliance and Distant Horizons of the Next Decade
Dalton Venture's Sun Qi: Unlocking a New Era of Industrial Biotechnology with the Power of "Life Derives All Things," Embracing China's Golden Decade of Biomanufacturing | Dalton Insights
Bio-manufacturing: The "Next Decade" of the Global Industrial Landscape
Wanwu Capital's Bio-Manufacturing Industry Partners Conference Convenes in Shanghai! Shanghai's First Bio-Manufacturing Industry Fund Launches, Partners Discuss the Golden Decade
On the afternoon of October 23, 2025, the "Sheng Yan Wan Wu | Bio-Manufacturing Industry Value Partners Conference," co-hosted by Dalton Venture and OPM Biosciences [688293], was held in Shanghai. Centered on the theme "Sheng Yan Wan Wu" (Life Begets All Things), the conference brought together representatives from government agencies, scholars from research institutes, industry-leading entrepreneurs, fund investors, and ecosystem partners to explore cutting-edge trends in bio-manufacturing and pathways for industrial collaboration.